Skip Ribbon Commands
Skip to main content

United States

Report | Global Life Sciences Cluster Report - 2012

Summary

​In the new reality for life sciences companies – one where the product development formula of the past no longer applies, where extensive M&A activity is needed to fill pipelines and mitigate risk, and where an increasing amount of attention and opportunity lie in emerging markets – prudent measures and strategic solutions are critical to succeed. More than ever, it is essential to achieve the ideal portfolio balance, with the proper size and type of facilities in the right locations.

To access the report, simply complete the form.

Please fill out the form to access the report.
Trouble downloading? Please click the following link.